Table of Contents Author Guidelines Submit a Manuscript
Nursing Research and Practice
Volume 2013, Article ID 504915, 8 pages
http://dx.doi.org/10.1155/2013/504915
Review Article

Evaluating Symptoms to Improve Quality of Life in Patients with Chronic Stable Angina

UTHSC College of Nursing, 920 Madison Avenue, Memphis, TN 38163, USA

Received 19 June 2013; Revised 15 August 2013; Accepted 11 October 2013

Academic Editor: Kyungeh An

Copyright © 2013 Jeffrey W. Young and Sheila Melander. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Pragodpol and C. Ryan, “Critical review of factors predicting health-related quality of life in newly diagnosed coronary artery disease patients,” Journal of Cardiovascular Nursing, vol. 28, no. 3, pp. 277–284, 2013. View at Google Scholar
  2. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart Disease and Stroke Statistics–2013 Update: A Report From the American Heart Association,” Circulation, vol. 127, no. 1, pp. e6–e245, 2013. View at Publisher · View at Google Scholar
  3. J. F. Beltrame, A. J. Weekes, C. Morgan, R. Tavella, and J. A. Spertus, “The prevalence of weekly angina among patients with chronic stable angina in primary care practices: the coronary artery disease in general practice (CADENCE) Study,” Archives of Internal Medicine, vol. 169, no. 16, pp. 1491–1499, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. D. Fihn, J. M. Gardin, J. Abrams et al., “2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Turgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons,” Circulation, vol. 126, pp. e354–e471, 2012. View at Google Scholar
  5. K. P. Alexander, L. J. Shaw, E. R. Delong, D. B. Mark, and E. D. Peterson, “Value of exercise treadmill testing in women,” Journal of the American College of Cardiology, vol. 32, no. 6, pp. 1657–1664, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. McSweeney, M. Cody, P. O'Sullivan, K. Elberson, D. K. Moser, and B. J. Garvin, “Women's early warning symptoms of acute myocardial infarction,” Circulation, vol. 108, no. 21, pp. 2619–2623, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. K. A. Milner, M. Funk, S. Richards, R. M. Wilmes, V. Vaccarino, and H. M. Krumholz, “Gender differences in symptom presentation associated with coronary heart disease,” American Journal of Cardiology, vol. 84, no. 4, pp. 396–399, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. D. S. Vadnais and N. K. Wenger, “Management options in chronic stable angina pectoris: focus on ranolazine,” Clinical Medicine Insights, vol. 1, pp. 871–887, 2009. View at Google Scholar
  9. V. Sangareddi, A. Chockalingam, G. Gnanavelu, T. Subramaniam, V. Jagannathan, and S. Elangovan, “Canadian Cardiovascular Society classification of effort angina: an angiographic correlation,” Coronary Artery Disease, vol. 15, no. 2, pp. 111–114, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. W. Gardner, P. S. Montgomery, R. M. Ritti-Dias, and U. Thadani, “Exercise performance, physical activity, and health-related quality of life in participants with stable angina,” Angiology, vol. 62, no. 6, pp. 461–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Myers, M. Prakash, V. Froelicher, D. Do, S. Partington, and J. Edwin Atwood, “Exercise capacity and mortality among men referred for exercise testing,” The New England Journal of Medicine, vol. 346, no. 11, pp. 793–801, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Mozaffarian, C. L. Bryson, J. A. Spertus, M. B. McDonell, and S. D. Fihn, “Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease,” American Heart Journal, vol. 146, no. 6, pp. 1015–1022, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. American Diabetes Association, “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. 11–63, 2012. View at Google Scholar
  14. N. G. Boulé, E. Haddad, G. P. Kenny, G. A. Wells, and R. J. Sigal, “Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials,” The Journal of the American Medical Association, vol. 286, no. 10, pp. 1218–1227, 2001. View at Google Scholar · View at Scopus
  15. R. F. Nease Jr., T. Kneeland, G. T. O'Connor et al., “Variation in patient utilities for outcomes of the management of chronic stable angina: implications for clinical practice guidelines,” The Journal of the American Medical Association, vol. 273, no. 15, pp. 1185–1190, 1995. View at Google Scholar · View at Scopus
  16. J. A. Spertus, J. A. Winder, T. A. Dewhurst, R. A. Deyo, and S. D. Fihn, “Monitoring the quality of life in patients with coronary artery disease,” American Journal of Cardiology, vol. 74, no. 12, pp. 1240–1244, 1994. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Spertus, P. Jones, M. McDonell, V. Fan, and S. D. Fihn, “Health status predicts long-term outcome in outpatients with coronary disease,” Circulation, vol. 106, no. 1, pp. 43–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Höfer, A. Saleem, J. Stone, R. Thomas, H. Tulloch, and N. Oldridge, “The MacNew heart disease health-related quality of life questionnaire in patients with angina and patients with ischemic heart failure,” Value in Health, vol. 15, no. 1, pp. 143–150, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Höfer, L. Lim, G. Guyatt, and N. Oldridge, “The MacNew heart disease health-related quality of life instrument: a summary,” Health and Quality of Life Outcomes, vol. 2, article no. 3, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. R. F. Heller, J. C. Knapp, L. A. Valenti, and A. J. Dobson, “Secondary prevention after acute myocardial infarction,” American Journal of Cardiology, vol. 72, no. 11, pp. 759–762, 1993. View at Publisher · View at Google Scholar · View at Scopus
  21. R. F. Heller, L. Lim, L. Valenti, and J. Knapp, “Predictors of quality of life after hospital admission for heart attack or angina,” International Journal of Cardiology, vol. 59, no. 2, pp. 161–166, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. C. E. Ferrans and M. Powers, “Quality of life index,” 1984, http://www.uic.edu/orgs/qli.
  23. L. L. Allen, M. Haririfar, J. Cohen, and M. J. Henderson, “Quality of life and locus of control of migraineurs,” Clinical Excellence for Nurse Practitioners, vol. 4, no. 1, pp. 41–49, 2000. View at Google Scholar · View at Scopus
  24. J. S. Anderson and C. E. Ferrans, “The quality of life of persons with chronic fatigue syndrome,” Journal of Nervous and Mental Disease, vol. 185, no. 6, pp. 359–367, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Daumer and P. Miller, “Effects of cardiac rehabilitation on psychosocial functioning and life satisfaction of coronary artery disease clients,” Rehabilitation Nursing, vol. 17, no. 2, pp. 69–86, 1992. View at Google Scholar · View at Scopus
  26. M. A. Hlatky, R. E. Boineau, M. B. Higginbotham et al., “A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index),” American Journal of Cardiology, vol. 64, no. 10, pp. 651–654, 1989. View at Google Scholar · View at Scopus
  27. Gilead Sciences, “The speak from the heart chronic angina checklist,” 2012, http://www.speakfromtheheart.com/angina-assessment.aspx.
  28. T. M. Maddox, K. J. Reid, J. A. Spertus et al., “Angina at 1 year after myocardial infarction: prevalence and associated findings,” Archives of Internal Medicine, vol. 168, no. 12, pp. 1310–1316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. R. van der Does, R. Eberhardt, I. Derr, B. Ehmer, J. Rudorf, and H. J. Uberbacher, “Treatment of chronic stable angina with carvedilol in comparison with nifedipine s.r,” European Heart Journal, vol. 12, no. 1, pp. 60–64, 1991. View at Google Scholar · View at Scopus
  30. A. Lahiri, E. A. Rodrigues, and I. Al-Khawaja, “Effects of a new vasodilating beta-blocking drug, carvedilol, on left ventricular function in stable angina pectoris,” American Journal of Cardiology, vol. 59, no. 8, pp. 769–774, 1987. View at Google Scholar · View at Scopus
  31. E. A. Rodrigues, A. Lahiri, and L. O. Hughes, “Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity,” American Journal of Cardiology, vol. 58, no. 10, pp. 916–921, 1986. View at Google Scholar · View at Scopus
  32. K. Robinson, S. Krikler, and D. M. Krikler, “Comparative study of the effect of nifedipine versus diltiazem on exercise performance, serum propranolol levels, and ST-segment abnormalities in patients with chronic stable angina taking propranolol,” American Journal of Cardiology, vol. 64, no. 11, pp. F27–F30, 1989. View at Google Scholar · View at Scopus
  33. P. Steele and F. Gold, “Favorable effects of acebutolol on exercise performance and angina in men with coronary artery disease,” Chest, vol. 82, no. 1, pp. 40–43, 1982. View at Google Scholar · View at Scopus
  34. G. Lee, A. N. DeMaria, L. Favrot et al., “Efficacy of acebutolol in chronic stable angina using single-blind and randomized double-blind protocol,” Journal of Clinical Pharmacology, vol. 22, no. 8-9, pp. 371–378, 1982. View at Google Scholar · View at Scopus
  35. R. DiBianco, S. Singh, J. B. Singh et al., “Effects of acebutolol on chronic stable angina pectoris. A placebo-controlled, double-blind, randomized crossover study,” Circulation, vol. 62, no. 6, pp. 1179–1187, 1980. View at Google Scholar · View at Scopus
  36. M. Romano, T. Di Maro, G. Carella et al., “Atenolol and/or nifedipine in effort angina: which is the treatment of choice for exercise coronary protection?” International Journal of Clinical Pharmacology Therapy and Toxicology, vol. 26, no. 9, pp. 468–470, 1988. View at Google Scholar · View at Scopus
  37. E. Southall, N. R. Nutt, and R. D. Thomas, “Chronic stable angina: comparison of verapamil and propranolol,” Journal of International Medical Research, vol. 10, no. 5, pp. 361–366, 1982. View at Google Scholar · View at Scopus
  38. P. H. Stone, J. H. Ware, M. A. DeWood et al., “The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind placebo-controlled clinical trial,” American Heart Journal, vol. 116, no. 4, pp. 961–971, 1988. View at Google Scholar · View at Scopus
  39. A. C. Tweddel, J. M. Beattie, R. G. Murray, and I. Hutton, “The combination of nifedipine and propranolol in the management of patients with angina pectoris,” British Journal of Clinical Pharmacology, vol. 12, no. 2, pp. 229–233, 1981. View at Google Scholar · View at Scopus
  40. K. Boman, H. Saetre, L.-G. Karlsson et al., “Antianginal effect of conventional and controlled release diltiazem in stable angina pectoris,” European Journal of Clinical Pharmacology, vol. 49, no. 1-2, pp. 27–30, 1995. View at Google Scholar · View at Scopus
  41. M. D. Ezekowitz, K. Hossack, J. L. Mehta et al., “Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial,” American Heart Journal, vol. 129, no. 3, pp. 527–535, 1995. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Erikssen, K. Osvik, and J. Dedichen, “Atenolol in the treatment of angina pectoris,” Acta Medica Scandinavica, vol. 201, no. 6, pp. 579–584, 1977. View at Google Scholar · View at Scopus
  43. S. M. Johnson, D. R. Mauritson, J. R. Corbett, W. Woodward, J. T. Willerson, and L. D. Hillis, “Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris,” American Journal of Medicine, vol. 71, no. 3, pp. 443–451, 1981. View at Google Scholar · View at Scopus
  44. H.-D. Faulhaber, I. Weigmann, U. Lang, F. Weinsberg, and B. Terhaag, “Anti-anginal and anti-ischemic effects of the selective β-blocker talinolol in patients with stable angina pectoris,” International Journal of Clinical Pharmacology and Therapeutics, vol. 43, no. 2, pp. 63–70, 2005. View at Google Scholar · View at Scopus
  45. D. M. Shavelle, “Long term medical treatment of stable coronary disease,” Heart, vol. 93, no. 11, pp. 1473–1477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. J. A. Spertus, T. Dewhurst, C. M. Dougherty, and P. Nichol, “Testing the effectiveness of converting patients to long-acting antianginal medications: the quality of life in angina research trial (QUART),” American Heart Journal, vol. 141, no. 4, pp. 550–558, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. V. Fuster, R. A. O'Rourke, P. Poole-Wilson, and R. A. Walsh, Hurst's the Heart, McGraw-Hill, New York, NY, USA, 2008.
  48. U. Thadani and T. L. Ripley, “Side effects of using nitrates to treat heart failure and the acute coronary syndromes, unstable angina and acute myocardial infarction,” Expert Opinion on Drug Safety, vol. 6, no. 4, pp. 385–396, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Doumas and S. Douma, “The effect of antihypertensive drugs on erectile function: a proposed management algorithm,” Journal of Clinical Hypertension, vol. 8, no. 5, pp. 359–364, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. M. A. van Baak, R. O. B. Bohm, B. G. Arends, M. E. J. van Hooff, and K. H. Rahn, “Long-term antihypertensive therapy with beta-blockers: submaximal exercise capacity and metabolic effects during exercise,” International Journal of Sports Medicine, vol. 8, no. 5, pp. 342–347, 1987. View at Google Scholar · View at Scopus
  51. S. G. Chrysant, S. P. Glasser, N. Bittar et al., “Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris,” American Journal of Cardiology, vol. 72, no. 17, pp. 1249–1256, 1993. View at Publisher · View at Google Scholar · View at Scopus
  52. D. T. Danahy and W. S. Aronow, “Hemodynamics and antianginal effects of high dose oral isosorbide dinitrate after chronic use,” Circulation, vol. 56, no. 2, pp. 205–212, 1977. View at Google Scholar · View at Scopus
  53. D. T. Danahy, D. T. Burwell, W. S. Aronow, and R. Prakash, “Sustained hemodynamic and antianginal effect of high dose oral isosorbide dinitrate,” Circulation, vol. 55, no. 2, pp. 381–387, 1977. View at Google Scholar · View at Scopus
  54. J. M. Walker, P. V. L. Curry, A. E. Bailey, and S. E. Steare, “A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina,” International Journal of Cardiology, vol. 53, no. 2, pp. 117–126, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. N. H. Brodie, H. O'Hara, J. O'Hara, and J. C. Valle-Jones, “Randomized crossover trial of isosorbide mononitrate (“Elantan” 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris,” Pharmatherapeutica, vol. 4, no. 6, pp. 367–375, 1985. View at Google Scholar · View at Scopus
  56. G. Nyberg, P. Carlens, E. Lindstrom et al., “The effect of isosorbide-5-mononitrate (5-ISMN) Durules on exercise tolerance in patients with exertional angina pectoris. A placebo controlled study,” European Heart Journal, vol. 7, no. 10, pp. 835–842, 1986. View at Google Scholar · View at Scopus
  57. J. Abrams and U. Thadani, “Therapy of stable angina pectoris: the uncomplicated patient,” Circulation, vol. 112, no. 15, pp. e255–e259, 2005. View at Google Scholar · View at Scopus
  58. J. Wei, T. Wu, Q. Yang, M. Chen, J. Ni, and D. Huang, “Nitrates for stable angina: a systematic review and meta-analysis of randomized clinical trials,” International Journal of Cardiology, vol. 146, no. 1, pp. 4–12, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. B. R. Chaitman, S. L. Skettino, J. O. Parker et al., “Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina,” Journal of the American College of Cardiology, vol. 43, no. 8, pp. 1375–1382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  60. B. R. Chaitman, C. J. Pepine, J. O. Parker et al., “Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial,” The Journal of the American Medical Association, vol. 291, no. 3, pp. 309–316, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. S. V. Arnold, D. A. Morrow, K. Wang et al., “Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial,” Circulation, vol. 1, no. 2, pp. 107–115, 2008. View at Google Scholar · View at Scopus
  62. P. H. Stone, N. A. Gratsiansky, A. Blokhin, I.-Z. Huang, and L. Meng, “Antianginal efficacy of ranolazine when added to treatment with amlodipine. The ERICA (Efficacy of Ranolazine in Chronic Angina) trial,” Journal of the American College of Cardiology, vol. 48, no. 3, pp. 566–575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. S. R. Wilson, B. M. Scirica, E. Braunwald et al., “Efficacy of ranolazine in patients with chronic angina. observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (metabolic efficiency with ranolazine for less ischemia in non-ST-segment elevation acute coronary syndromes) 36 trial,” Journal of the American College of Cardiology, vol. 53, no. 17, pp. 1510–1516, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. M. J. Koren, M. R. Crager, and M. Sweeney, “Long-term safety of a novel antianginal agent in patients with severe chronic stable angina. the ranolazine open label experience (ROLE),” Journal of the American College of Cardiology, vol. 49, no. 10, pp. 1027–1034, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. S. Pocock, “Coronary angioplasty versus medical therapy for angina: the second randomised intervention treatment of angina (RITA-2) trial,” The Lancet, vol. 350, no. 9076, pp. 461–468, 1997. View at Publisher · View at Google Scholar · View at Scopus
  66. A. F. Parisi, E. D. Folland, and P. Hartigan, “A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease,” The New England Journal of Medicine, vol. 326, no. 1, pp. 10–16, 1992. View at Google Scholar · View at Scopus
  67. P. Thomson, C. A. Niven, D. F. Peck, and J. Eaves, “Patients' and partners' health-related quality of life before and 4 months after coronary artery bypass grafting surgery,” BMC Nursing, vol. 12, article 16, no. 1, 2013. View at Google Scholar
  68. W. E. Boden, R. A. O'Rourke, K. K. Teo et al., “Optimal medical therapy with or without PCI for stable coronary disease,” The New England Journal of Medicine, vol. 356, no. 15, pp. 1503–1516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Pitt, D. Waters, W. V. Brown et al., “Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease,” The New England Journal of Medicine, vol. 341, no. 2, pp. 70–76, 1999. View at Publisher · View at Google Scholar · View at Scopus
  70. P. W. Serruys, A. T. L. Ong, L. A. van Herwerden et al., “Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial,” Journal of the American College of Cardiology, vol. 46, no. 4, pp. 575–581, 2005. View at Publisher · View at Google Scholar · View at Scopus